Skip to main content
OpenTrials
Completed

NCT Number: NCT07087665

Patient Reported Outcomes With WaveLight Plus LASIK

This study is a single-site, single-arm, prospective, observational study of subject satisfaction, quality of vision, and quality of life after bilateral LASIK surgery. Subjects will be assessed 6 months post-operatively. Clinical evaluations will include refractive outcomes, visual acuity, and administration of the adapted PROWL, QIRC, and OSDI questionnaires.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–37 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Ovo Lasik + Lens

Saint Louis Park, Minnesota, 55416, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subject must be able to understand and sign an approved consent form.
  • Willing and able to comply with scheduled visits and other study procedures.
  • Age: 18 to 37
  • Myopia with or without astigmatism and MRSE within the range indications for wavelight plus (myopia up to -8 D, astigmatism up to -3.0 D, S.E. more than -1.00 and up to -9.00D)
  • Pre-surgery BCDVA of 20/20 (0.00 logMAR) or better in each eye.
  • Stable refraction (within ± 0.50 D) as determined by manifest refraction spherical equivalent for a minimum of 12 months prior to surgery.
  • Refractive target of bilateral emmetropia
  • Mesopic pupil size ≥ 4.5mm
  • Less than 0.75 D spherical equivalent difference between Sightmap measured refraction SE and the subjective manifest refraction (MRSE)

Exclusion criteria

  • Subjects with a history of previous ocular surgery.
  • Subjects with topographic evidence of keratoconus or ectasia.
  • Pre-existing retinal or corneal pathology Subjects with autoimmune diseases.
  • Subjects who are pregnant or nursing.
  • Systemic disease likely to affect wound healing, such as diabetes and severe atopy.
  • Any ocular disease (including uncontrolled dry eye) in which the investigator's opinion would affect the outcome of refractive surgery.
  • Patients with a calculated residual stromal depth <250 µm would be excluded from the study.

Treatment and study plan

Wavelight Plus

Device

The WaveLight EX500 laser system, in conjunction with INNOVEYES Sightmap, is indicated for use in INNOVEYES Laser Assisted In-Situ Keratomileusis ("wavelight plus"1 LASIK) treatments:

  • or the reduction or elimination of myopia or myopia with astigmatism, in eyes with spherical equivalent (SE) more than -1.00 and up to -9.00 diopters (D), with up to -8.00 D of spherical component (in minus cylinder format) and up to -3.00 D of astigmatic component at the spectacle plane, based on the INNOVEYES Sightmap Measured Refraction,
  • in patients with magnitude of the spherical equivalent (SE) difference between the Manifest Refraction (MRSE) and the Sightmap measured refraction SE being less than 0.75D,
  • in patients who are 18 years of age or older, and
  • for patients with documentation of a stable manifest refraction defined as 0.5 D preoperative spherical equivalent shift over one year prior to surgery.

Primary outcomes

  1. Percentage of subjects satisfied (Completely Satisfied or Very Satisfied) with vision after Wavelight Plus LASIK based on an adapted PROWL Questionnaire (Question #1 only).

    Time frame: 6 months postoperatively

Secondary outcomes

  1. Remaining Vision quality and quality of life during daily tasks using the adapted PROWL

    Time frame: 6 months postoperatively

  2. The percentage of eyes at each monocular visual acuity (VA) level (uncorrected 20/10, 20/12.5, 20/16, 20/20, 20/25).

    Time frame: 6 months postoperatively

  3. The percentage of subjects at each binocular visual acuity (VA) level (uncorrected 20/10, 20/12.5, 20/16, 20/20, 20/25).

    Time frame: 6 months postoperatively

Sponsors and collaborators

Lead sponsor

OVO LASIK + Lens

Other

Collaborators

  • Sengi

Registry information

Official study title

Patient Satisfaction, Quality of Vision, and Quality of Life Following Treatment With WaveLight Plus LASIK

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Jul 28, 2025
Registry last updated
Jul 30, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.